ABC | Volume 111, Nº3, Setembro 2018

Diretrizes Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda Arq Bras Cardiol. 2018; 111(3):436-539 137. Cruz FD, Issa VS, Ayub-Ferreira SM, Chizzola PR, Souza GE, Moreira LF, et al. Effect of a sequential education andmonitoring programme on quality- of-life components in heart failure. Eur J Heart Fail. 2010;12(9):1009-15. 138. Deek H, Chang S, Newton PJ, Noureddine S, Inglis SC, Arab GA, et al. An evaluation of involving family caregivers in the self-care of heart failure patients on hospital readmission: Randomised controlled trial (the FAMILY study). Int J Nurs Stud. 2017;75:101-11. 139. Neubauer BE, Gray JT, Hemann BA. Heart failure optimizing recognition and management in outpatient settings. Prim Care. 2018;45:63–79. 140. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017ACC/AHA/HFSA FocusedUpdate of the 2013ACCF/AHAGuideline for the Management of Heart Failure: A Report of the American College of Cardiology/AmericanHeart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137-61. 141. Bui AL, Fonarow GC. Home monitoring for heart failure management. J Am Coll Cardiol. 2012;59(2):97–104. 142. Vedel I, Khanassov V. Transitional care for patients with congestive heart failure: a systematic review and meta-analysis. Ann Fam Med. 2015;13(6):562–57. 143. Naylor MD. Transitional care for older adults: a cost-effective model. LDI Issue Brief. 2014;9(6):1–4. 144. Arcand J, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, et al. A high-sodium diet is associatedwith acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr. 2011;93(2):332–7. 145. Son YJ, Lee Y, Song EK. Adherence to a sodium-restricted diet is associatedwith lower symptom burden and longer cardiac event-free survival inpatientswithheart failure. JClinNurs.2011;20(21-22):3029-38. 146. Parrinello G, Di Pasquale P, Licata G, Torres D, Giammanco M, Fasullo S, et al., 2009. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail. 2009;15(10):864-73. 147. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal- sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008;114(3):221-30. 148. Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, et al. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009;103(1):93-102. 149. Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, et al. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure withNewYork Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci. 2011;342(1):27-37. 150. Lennie TA, Song EK, Wu JR, Chung ML, Dunbar SB, Pressler SJ, et al. Threegram sodium intake is associatedwith longer event-free survival only inpatients with advanced heart failure. J Card Fail. 2011;17(4):325-30. 151. De Vecchis R, Baldi C, Cioppa C, Giasi A, Fusco A. Effects of limiting fluid intake on clinical and laboratory outcomes in patients with heart failure. Results of a meta-analysis of randomized controlled trials. Herz. 2016;41(1):63-75. 152. Albert NM, Nutter B, Forney J, Slifcak E, Tang WH. A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF). J Card Fail. 2013;19(1):1–9. 153. Holst M, Strömberg A, Lindholm M, Willenheimer R. Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity. Scand Cardiovasc J. 2008;42(5):316–22. 154. Lavie CJ, Sharma A, Alpert MA, De Schutter A, Lopez-Jimenez F, Milani RV, et al. Update on Obesity and Obesity Paradox in Heart Failure. Prog Cardiovasc Dis. 2016;58(4):393-400. 155. Rider OJ, Francis JM, Ali MK, Petersen SE, RobinsonM, RobsonMD, et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009;54(8):718-26. 156. Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathyafter bariatric surgery. J Card Fail. 2008;14(3):198–202. 157. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, LarsonMG, et al. Obesity and the risk of heartfailure. N Engl J Med. 2002;347(5):305–13. 158. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL,Webb-Peploe KM, et al. Wasting as independent riskfactor for mortality in chronic heart failure. Lancet. 1997;349(9058):1050-3. 159. Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact orfiction? Am J Cardiol 2006;98(7):944–8. 160. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo- controlled trial. Lancet. 2008;372(9645):1223-30. 161. Madmani ME, Yusuf Solaiman A, Tamr Agha K, Madmani Y, Shahrour Y, Essali A, et al. Coenzyme Q10 for heart failure. Cochrane Database Syst Rev. 2014;(6):CD008684. 162. Mortensen SA , Rosenfeldt F , Kumar A , Dolliner P , Filipiak KJ , Pella D , et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from QSYMBIO: a randomized doubleblind trial. JACC Heart Fail. 2014;2(6):641-9. 163. Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011;13(6):619–25. 164. Boxer RS, Kenny AM, Schmotzer BJ, Vest M, Fiutem JJ, Piña IL. A randomized controlled trial of high dose vitamin D3 in patients with heartfailure. JACC Heart Fail. 2013;1(1):84–90. 165. Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers HeerspinkHJ,etal.Short-termvitaminD3supplementation lowersplasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166(2):357-64.e2. 166. Jiang WL, Gu HB, Zhang YF, Xia QQ, Qi J, Chen JC. Vitamin D supplementation in the treatment of chronic heart failure: a metaanalysis of randomized controlled trials. ClinCardiol. 2016;39(1):56-61. 167. MohseniH,KiranA,KhorshidiR,RahimiK.Influenzavaccinationandriskfor hospitalization in patients with heart failure: a self-controlled case series study. Eur Heart J. 2017;38(5):326–3 168. Ciszewski A. Cardioprotective effect of influenza and pneumococcal vaccinationinpatientswithcardiovasculardiseases.Vaccine.2016;36(2)202–6. 169. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003;107(8):1210–25. 170. Ferraz AS, Bocchi EA, Guimarães GV, Meneghelo RS, Moreira DAR, Umeda II, et al. Effects of aerobic exercise training on autonomic balance, brain natriuretic peptide, and quality of life evaluation in dilated cardiomyopathy patients. a prospective randomized controlled study. Circulation. 2003;108(Suppl IV):739. 171. Cornelis J, Beckers P, Taeymans J, Vrints C, Vissers D. Comparing exercise trainingmodalities in heart failure: A systematic review andmeta-analysis. Int J Cardiol. 2016 Oct 15;221:867-76. 172. Ferraz AS, Boochi EA. Efeitos do treinamento físico na morbidade e mortalidade em pacientes com IC: como implementar sua aplicação na pratica clínica. Rev Soc Cardiol Estado de São Paulo. 2008;18(1):23-36. 521